In an interview from #ECTRIMS2024, Helen Tremlett introduces the concept of a prodromal phase in #MultipleSclerosis and comments on how it has been neglected.
Watch it here:
👉 https://buff.ly/3B1PiVt
#MultScler #MS #Neuroscience #Neurology
Watch it here:
👉 https://buff.ly/3B1PiVt
#MultScler #MS #Neuroscience #Neurology
December 5, 2024 at 12:00 PM
In an interview from #ECTRIMS2024, Helen Tremlett introduces the concept of a prodromal phase in #MultipleSclerosis and comments on how it has been neglected.
Watch it here:
👉 https://buff.ly/3B1PiVt
#MultScler #MS #Neuroscience #Neurology
Watch it here:
👉 https://buff.ly/3B1PiVt
#MultScler #MS #Neuroscience #Neurology
ECTRIMS 2024
Sign up to tune in online, for free. I certainly will be doing so!
While Prof Gavin Giovannoni is no longer doing clinical work, he’s still heavily involved in the #MS world
ectrims.eu/ectrims2024-...
Sign up to tune in online, for free. I certainly will be doing so!
While Prof Gavin Giovannoni is no longer doing clinical work, he’s still heavily involved in the #MS world
ectrims.eu/ectrims2024-...
ECTRIMS2024 - ECTRIMS Patient Community Day
ectrims.eu
August 8, 2024 at 3:20 PM
ECTRIMS 2024
Sign up to tune in online, for free. I certainly will be doing so!
While Prof Gavin Giovannoni is no longer doing clinical work, he’s still heavily involved in the #MS world
ectrims.eu/ectrims2024-...
Sign up to tune in online, for free. I certainly will be doing so!
While Prof Gavin Giovannoni is no longer doing clinical work, he’s still heavily involved in the #MS world
ectrims.eu/ectrims2024-...
#ECTRIMS2024 | Emilio Portaccio outlines the two ways disability accrual occurs in #MultipleSclerosis – relapse-associated worsening (RAW) & progression independent from relapse activity (PIRA).
Click here:
👉 https://buff.ly/4gZeUl3
#MultScler #MS #Neurology #Neuroscience
Click here:
👉 https://buff.ly/4gZeUl3
#MultScler #MS #Neurology #Neuroscience
January 6, 2025 at 1:00 PM
#ECTRIMS2024 | Emilio Portaccio outlines the two ways disability accrual occurs in #MultipleSclerosis – relapse-associated worsening (RAW) & progression independent from relapse activity (PIRA).
Click here:
👉 https://buff.ly/4gZeUl3
#MultScler #MS #Neurology #Neuroscience
Click here:
👉 https://buff.ly/4gZeUl3
#MultScler #MS #Neurology #Neuroscience
Earlier this year, we interviewed Maya Zeineddine to hear about the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in #MultipleSclerosis.
Watch here:
👉 https://buff.ly/3ZAA42V
#MS #MultScler #ECTRIMS2024 #Neuroscience
Watch here:
👉 https://buff.ly/3ZAA42V
#MS #MultScler #ECTRIMS2024 #Neuroscience
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS - VJNeurology
Maya Zeineddine, PharmD, Lebanese American University, Byblos, Lebanon, discusses the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in...
buff.ly
December 13, 2024 at 2:00 PM
Earlier this year, we interviewed Maya Zeineddine to hear about the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in #MultipleSclerosis.
Watch here:
👉 https://buff.ly/3ZAA42V
#MS #MultScler #ECTRIMS2024 #Neuroscience
Watch here:
👉 https://buff.ly/3ZAA42V
#MS #MultScler #ECTRIMS2024 #Neuroscience
#CARTCell therapy has revolutionized the treatment of hematological malignancies and is now being considered as a potential treatment for neurological conditions, including #MultipleSclerosis!
Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG
#ECTRIMS2024 #MS #MultScler
Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG
#ECTRIMS2024 #MS #MultScler
Investigating CAR T-cell therapy in the treatment of MS - VJNeurology
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA, discusses the potential use of chimeric antigen receptor (CAR) T-cell therapy to...
buff.ly
December 9, 2024 at 2:00 PM
#CARTCell therapy has revolutionized the treatment of hematological malignancies and is now being considered as a potential treatment for neurological conditions, including #MultipleSclerosis!
Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG
#ECTRIMS2024 #MS #MultScler
Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG
#ECTRIMS2024 #MS #MultScler
It was a pleasure to interview Anneke Van der Walt, who provided insight into evobrutinib and other BTK inhibitors for the treatment of #MultipleSclerosis.
Click here to watch:
👉 https://buff.ly/3Z8JMbw
#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
Click here to watch:
👉 https://buff.ly/3Z8JMbw
#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
Investigating evobrutinib and other BTK inhibitors for the treatment of MS - VJNeurology
Anneke Van der Walt, PhD, Monash University, Melbourne, Australia, discusses the use of evobrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor,...
buff.ly
December 7, 2024 at 5:00 PM
It was a pleasure to interview Anneke Van der Walt, who provided insight into evobrutinib and other BTK inhibitors for the treatment of #MultipleSclerosis.
Click here to watch:
👉 https://buff.ly/3Z8JMbw
#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
Click here to watch:
👉 https://buff.ly/3Z8JMbw
#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
September 20, 2024 at 6:58 AM